E.U. Agency in Limbo as Hidden Costs of ‘Brexit’ Continue to Mount

The likely move of the European Medicines Agency, currently in Britain, has worrying implications for the country’s vibrant biotech and pharmaceuticals sector.

from NYT > Health http://ift.tt/2it9i9o
via health&fitness